ABSTRACT Extracellular matrix (ECM), prepared from chick embryo fibroblasts, contains fibronectin as the major structural protein along with collagen and other polypeptides as less abundant protein components. When Rous sarcoma virus-transformed chick embryo fibroblasts are cultured on the ECM in the presence of the tumor promoter tetradecanoyl phorbol acetate, the transformed cells lose their characteristic rounded morphology and align on and within the ECM fibrillar network. This restrictive aspect of ECM is only temporary, however, and with time (24-72 h) the transformed cells progressively degrade the ECM fibers and resume their rounded appearance. The matrix degradation can be monitored by employing biosynthetically radiolabeled ECM. The addition of purified chicken plasminogen to the Rous sarcoma virus-transformed chick embryo fibroblast cultures enhances the rate and extent of ECM degradation, due to the elevated levels in the transformed cultures of plasminogen activator. Plasminogen-dependent and -independent degradation of ECM has been characterized with regard to sensitivity to various natural and synthetic protease inhibitors and to the requirement of celI/ECM contact. Plasminogen-dependent degradation of ECM occurs rapidly when ECM and cells are in contact or separated, whereas plasminogen-independent degradation is greatly reduced when ECM and cells are separated, which suggests that cell surfaceassociated proteolytic enzymes are involved. A possible role in ECM degradation has been indicated for cysteine proteases, metallo enzymes, and plasminogen activator, the latter as both a zymogen activator and a direct catalytic mediator.
in certain disease states. Malignant cells can escape the ECMimposed restriction by modifying and breaking down the matrix network in vivo. This is often observed in histological sections of tumor tissue as "tongues" of malignant cells clearing away ECM and penetrating surrounding normal tissue (16) . As an experimental model for this process a number of investigators have cultured malignant cells on ECM in vitro and observed that the cells actively clear the ECM by solubilizing and degrading the matrix components (17) (18) (19) (20) (21) (22) . However, a number of laboratories also have demonstrated that when malignant cells are cultured on ECM, the matrix, or its individual components, imposed morphological and locomotory restriction on the cells, causing them to adhere firmly and align on and within the ECM network (9, 23-26). These apparent experimental contradictions may be related to the nature of the malignant ceils being examined, the histological origin of the ECM employed as the substratum, and the biological and temporal limitations of the different experimental approaches.
We have been using normal chick embryo fibroblasts (CEFs) and Rous sarcoma virus-transformed chick embryo fibroblasts (RSVCEFs) to examine the role of specific proteolytic enzymes in modulating the behavior of the RSVCEF transformants (27-32). Normal CEFs have been shown to produce an abundant ECM (5), which may have a direct effect on the morphology and behavior of CEF cultures and the transformants that arise after infection of the CEFs with RSV. Therefore we were interested in examining the effect of ECM, isolated from cultures of normal CEFs, on homologous cultures of RSVCEFs, and in determining the effect of the elevated levels of RSVCEF proteolytic enzymes on such matrices. Our results indicate that ECM initially has a pronounced restrictive effect on the behavior of the transformants but that in time the transformed cells overcome that restriction by catalytically degrading the ECM using a number of enzyme systems.
MATERIALS AND METHODS
Cell Cultures: Primary CEFs were prepared from I 0-12<1 old embryos (33) . The cultures were grown in Eagle's minimal essential medium (MEM) containing high glucose, penicillin, and streptomycin and supplemented with 10% heat-inactivated fetal calf serum (FCS) . CEF secondary cultures were infected and transformed with RSV as described previously (27, 28) . All experiments were performed on second, third, and fourth passage cultures of CEFs and RSVCEFs.
Preparation of ECM:
Trial preparations of ECM were carried out according to a number of different methods (9, 18, 20, 34) . The method used for all preparations was a modification of the procedures described by Jones and De Clerk (18) . Petri dishes were seeded with CEFs (4 x 10 ~ cells in 35-mm dishes) and incubated in MEM supplemented with 10% FCS in the presence or absence of ascorbic acid (50 ~g/ml) added fresh daily. When the cultures reached confluence they were washed once with phosphate-buffered saline (PBS) deficient in calcium and magnesium containing 5 mM EDTA and incubated in the same solution for 10 min at 37"C. The partially detached cells were lysed away from the underlying ECM by a wash and two 10-rain incubations with 0.025 M NH4OH at room temperature. The ECM and remaining material was washed twice with PBS deficient in calcium and magnesium. The matrices, still firmly attached to the petri dishes, were sterilized with 70% ethanol for 10-15 min, stored in PBS at 4°C, and used for experiments within 1 wk.
Radiolabeling of ECM: 1-2 d after CEFs were seeded when the cultures were 50-75% confluent, I3~S]methionine (10 uCi/ml) was introduced to the cultures in fresh medium containing one-twentieth of the normal MEM concentration of methionine. When the cultures had reached confluence the matrices were prepared as described above.
Treatmerlt of ECM:
Radiolabeled preparations of ECM were washed FAIRBAIRN ET AL.
in PBS and incubated under one of the following conditions. Condition A: 1 ml of 5 mM CaCI2, 10 mM N-ethylmaleimide, 50 mM Tris-HCI, pH 7.5, containing 260 U collagenase for 1 h at 37"C. Collagenase activity was terminated by the addition of 10 mM EDTA. Condition B: 1 ml of 100 mM Tris-HC1, pH 8.0, containing 0.25 #g trypsin for I h at 37"C. Trypsin activity was terminated by the addition of 5/~g soybean trypsin inhibitor. Condition C: 1 ml trypsin under incubation condition B for I h, termination with soybean trypsin inhibitor, wash with PBS, addition of I ml eollagenase under incubation condition ,4 for 1 h, and termination with EDTA. After each enzyme treatment the radioactivity released from the ECM was determined (see below), and the residual ECM was solubilized and analyzed by PAGE (see below).
ECM Degradation Assay:
Radiolabeled ECM preparations were washed with MEM before cells (CEFs or RSVCEFs) were seeded onto them at 1.5 × 106 cells/35-mm dish in MEM containing 5% plasminogen-depleted FCS prepared as previously described (35) . Approximately 18-24 h later the cultures were washed with MEM and incubated in 2 ml serum-free MEM in the presence or absence of 100 ng/ml of tetradecanoyl phorbol acetate (TPA). At selected intervals thereafter triplicate representative dishes were taken for analysis. The supernatant was removed, phenylmethylsulfonyl fluoride was added to a final concentration of 2 mM, and a 200-ul aliquot was mixed with 5 ml Aquasol-2 and counted in a beta-liquid scintillation counter. The remaining supernatant was frozen for later analysis or dialyzed and lyophilized in preparation for PAGE (see below). The remaining ECM and cells were collected from the dishes by scraping in 0.5 ml 1% SDS. A 50-~1 aliquot was added to 5 ml Aquasol-2 and counted in a beta-liquid scintillation counter. The total counts per minute in the supernatant and residual matrix were calculated, and the percent radioactivity released was based on counts per minute in supernatant/ total counts per minute in supernatant + matrix x 100. The amount of radiolabeled protein in the matrix and released into the supernatant was also quantitated by ice-cold 5% trichloroacetic acid (TCA) precipitation of protein onto Millipore HF l-in filter disks (Millipore Corp., Bedford, MA). The disks were dried under a heat lamp, placed into 5 ml Aquasol-2, and counted in a beta-liquid scintillation counter.
Preparation of ECM for Separation and Cell Contact Degradation Studies:
ECM was prepared on 35-mm dishes as described above. The vertical sides of the dishes were cut away from the base, leaving the ECM intact on a plastic 35-ram disk, which was sterilized in 70% ethanol and air-dried. Under these conditions, surface tension allowed the plastic disk to be floated on medium with the ECM facing downward in a 60-ram culture dish 1-2 mm above a monolayer of cells. Alternatively, the plastic disk could be rewetted with medium and submerged on the bottom of a 60-ram culture dish with the ECM facing upward. A cell suspension was added to the dish, allowing the ceils to attach directly to the ECM.
5D5 PAGE: Samples of supernatant and resuspended matrices were mixed with appropriate volumes of concentrated electrophoresis sample buffer (36) containing 5% beta-mercaptoethanol, boiled, and applied directly on 8.5% polyacrylamide slab gels using the system of Laemmli (36) . Alternatively, samples were dialyzed against 500 vol 0.01% SDS, lyophilized, and taken up in electrophoresis sample buffer containing 5% beta-mercaptoethanol, boiled, and analyzed on 8.5% polyacrylamide slab gels. Unless otherwise noted, equal volumes of supernatant and equal volumes ofresuspended matrices corresponding to one culture dish or an equal fraction thereof were applied onto the gels. After electrophoresis, the gels were stained in 0.25% Coomassie Blue in 50% methanol, 8% acetic acid for 1-2 h at 37"C and destained with several changes of 5% methanol, 12% acetic acid. Autoradiography was performed on gels containing 35S-labeled proteins with Kodak R film, Ready pack. Molecular weight standards were run in parallel lanes and included myosin (200,000), Bgalactosidase (135,000), bovine serum albumin (67,000), ovalbumin (43,000), chymotrypsinogen (25,000), and cytochrome c (12,000).
Microscopy: Cells cultured on matrices that had been prepared on strips (6 x 20 ram) of tissue culture plastic cut from Lax petri dishes (Lux Scientific Inc., Newbury Park, CA) were fixed with 1.5% glutaraldehyde in 0.1 M potassium phosphate, pH 7.4, for 1 h and washed overnight at 4*(" in the phosphate buffer. Fixed samples were prepared for scanning electron microscopy by critical point drying, coated with evaporated gold, and examined with a JEOL 100C electron microscope in the scanning mode. Samples for phase microscopy were examined with an inverted phase microscope and photographed with a Polaroid camera. ECM-containing dishes were prepared and analyzed for immunofluorescence using an anti--chicken fibronectin antiserum (37, 38) .
Preparation of Plasminogen, Plasminogen-free Serum, and
Acid-treated Serum: FCS and chicken serum were selectively freed of plasminogen by two passages over a lysine-Sepharose affinity column according to established procedures (35). The serum was assayed with purified plasminogen activator (PA) (39) and shown to be 95-100% plasminogen free. Plasmin-ogen was eluted from the lysine-Sepharose with 0.2 M epsilon-amino caproic acid in PBS containing 5 mM EDTA. The plasminogen was judged to be homogeneous by SDS PAGE and was resolved as a single protein band at 95,000 D. Acid-sensitive protease inhibitors in serum were inactivated by the addition of 1 N HCI to serum, bringing the pH to 3.0-3.5. The serum was incubated at room temperature for 2 h and reneutralized to pH 7.4 with the addition of I N NaOH. This procedure destroys ~90% of the protease inhibitory capacity of FCS (40) .
PA Assa y: PA activity was based on the plasmin-mediated hydrolysis of ~251 fibrin and measured as described previously (27) (28) (29) (30) . 1 U PA activity is equivalent to the release of 2,000 cpm t251 in 2 h at 37°C in the presence of 5 lag purified chicken plasminogen. Fibrin, free of plasminogen, was prepared as previously described (41 ) . 
Materials:

RESULTS
Preparation and Characterization of ECM from Monolayer Cultures of CEFs
Growing cultures of CEFs were incubated with [35S]methionine to radiolabel the protein components of the ECM. When ECM is prepared from radiolabeled CEF cultures that have been grown in the presence and absence of ascorbic acid (50 tzg/ml) the matrix preparations are qualitatively similar, with some quantitative differences due to increases in procollagen-like molecules (Fig. 1A) . Fibronectin is the major polypeptide of both preparations, composing >75% of the total radiolabeled polypeptides (as determined by densimetric scanning). Matrices prepared from ascorbic acid-treated cultures exhibit an increase in two sets of polypeptide doublets corresponding to apparent molecular weights of 145,000/155,000 and 180,000/185,000, which co-migrate with a preparation of chicken type I procollagen/collagen. Treating this matrix with collagenase releases only 3-4% of the total radioactivity, and the resulting ECM polypeptide pattern appears unchanged ( Fig. i B, lane 2) . Trypsin treatment, however, releases 50-60% of the total radioactivity, removing most of the fibronectin and some of the procollagen/collagen bands ( Fig. 1 B, lane 3) . If the trypsin-treated ECM is then incubated with collagenase, 5-10% of the original total radioactivity is released and the 150K and 180K bands are removed ( Fig.  1 B, lane 4) . These results indicate that whereas fibronectin is the major protein of ECM, collagen components are less abundant proteins and can only be released by collagenase after the removal of fibronectin and other trypsin-sensitive glycoproteins.
Indirect immunofluorescence with an antibody to fibronectin illustrates that the fibrillar arrays of the ECM stain heavily for fibronectin (data not shown), which is consistent with the dominance of fibronectin shown in the polyacrylamide gel pattern of 
Effect of Chick ECM on the Morphology of Transformed Chick Fibroblasts
It is well established that when CEFs are transformed by RSV their morphology is dramatically altered (42) , and this has been ascribed to the diminished production of ECM components by transformed cells (37, 43, 44) . It has also been shown that treatment of RSVCEF cultures with the tumor promoter TPA causes pronounced clustering of the transformed cells and a concomitant loss of the residual ECM substratum (28, 29, 45) . When transformed CEFs are incubated in serum-free medium on the ECM prepared from normal CEFs, distinct morphological changes are observed (Fig. 2) . The transformed cells appear more elongated, less refractile, and less randomly oriented (Figs. 2, c and d ). More striking is the effect of ECM on the TPA-treated RSVCEF cultures. The cell clustering brought about by TPA treatment (28, 29) is completely prevented by the presence of the ECM (Fig. 2, e and f) . The TPA-treated RSVCEF cells remain elongated and appear completely aligned on the underlying ECM. The inhibitory effect of intact ECM on cell clustering, however, is only temporary. If the TPA-treated cultures are incubated for an additional 25 h, the ECM appears to be lost and the cells become disorganized and eventually cluster (Fig. with or without normal CEFs since only from 5 to 8%, respectively, of the labeled material was released during a 48-h incubation. RSVCEFs, however, induce a progressive breakdown of ECM components, releasing 35% of the protein components after 48 h. Matrix degradation is dramatically increased by TPA-treated RSVCEF cultures, which released 40% of the radioactivity after 24 h and 70% after 48 h. The extensive solubilization of ECM polypeptides in the TPAtreated RSVCEF cultures correlates with the extensive cell clustering observed in Fig. 2h . That the pattern of matrix degradation was similar for ECM prepared in ascorbate-free and ascorbate-containing medium (Fig. 3) indicates that the increased collagen deposition did not affect the overall pattern of ECM solubilization by the transformed ceils.
Plasminogen-dependent and -independent Degradation of ECM
The degradation of ECM by transformed cells in serumfree medium observed in Fig. 3 can be enhanced by the addition of purified chicken plasminogen (Fig. 4) , and this increased rate of degradation is prevented by trasylol, an inhibitor of plasmin. This indicates that the elevated levels of PA (28) catalytically convert plasminogen to plasmin, which in turn rapidly degrades the ECM. Trasylol, however, had no effect on the cell-mediated ECM degradation, as 70-80% of the radiolabeled ECM was released over 48 h in either the presence or absence of trasylol (Fig. 4) . The polypeptides released from the ECM into the culture medium are shown in Fig. 5 and provide evidence that the cell-mediated degradation of ECM is distinct from the plasminogen-mediated degradation. The polypeptide pattern of the culture medium in MEM containing 5% plasminogen-depleted FCS onto plastic tissue culture dishes or dishes that contained ECM. After 24 h all cultures were washed in MEM and incubation was continued in serum-free MEM. Some of the RSVCEF cultures were supplemented with TPA (e-h) (100 ng/ml). Phase-contrast photomicrographs were taken 23 (a-f) or 48 h (g and h) after the addition of serum-free MEM.
The PA activity of CEFs, RSVCEFs, and TPA-treated RSVCEFs cultured on ECM was 0.46, 12.9, and 81.2 U/ culture, respectively, at 23 h, which demonstrates that the substantial increases in PA activity upon RSV transformation and TPA treatment (28, 29) are not reversed by culturing on ECM.
Alteration and Degradation of ECM by Transformed and TPA-treated Transformed Cells
Since the morphological studies indicated that the ECM was absent after a 48-h incubation of transformed cultures in TPA we decided to quantitate the apparent loss of ECM using 35S-radiolabeled matrices. Fig. 3 demonstrates that the ECM was relatively stable when incubated in serum-free medium of the culture dish. Little or no intact fibronectin is present in either supernatant.
When the radioactivity released into the different culture supernatants is analyzed by TCA precipitation, 72-93% of the released radioactivity remains acid precipitable. This indicates that most matrix proteins are released as partially degraded polypeptides, as illustrated in Fig. 5 , and not extensively broken down to acid-soluble peptides and amino acids. The radioactivity in untreated, intact matrices is 90-95% acid precipitable. The radioactivity released into the culture supernatants was also analyzed by Sephadex G100 chromatography: 10-33% of the released radioactivity is found in the void volume of the column; 30-66% of the released radioactivity is found in the included volume of the column; and only 12-27% is found in the column volume that corresponds to molecular weights <10,000. Approximately 80-90% of the radioactivity from untreated matrices elutes in the void volume. These results further demonstrate that partial degradation of matrix proteins occurs under the different culture conditions.
Effect of Protease Inhibitors on Cell-mediated ECM Degradation
Using selective protease inhibitors we further examined the nature of the cell-mediated, plasminogen-independent degradation (Fig. 6) . The protease inhibitors were added to cultures at concentrations that in prior experiments had been shown to have no effect on cell viability, cell plating efficiency, and cellular protein and RNA synthesis (29) . Diisopropylfluorophosphate, the general inhibitor of serine proteases (46), inhibits ECM degradation by RSVCEF cultures to 32-38% of control. The epoxide derivative E64c, an inhibitor of mammalian cysteine proteases (47), inhibits ECM degradation by 30-43%. The metallo-protease inhibitor, 1,10 phenanthroline, inhibits degradation by 40-53%. The combined use of all three inhibitors reduces ECM degradation by 80% (Fig.  6A) . NPGB, a potent inhibitor of arginine-preferring serine proteases (31), inhibits ECM degradation by 35 % (Fig. 7 B) , a percent inhibition similar to that observed for the more general serine protease inhibitor diisopropylfluorophosphate (Fig. 6 A) . Leupeptin, an inhibitor of arginine-preferring serine and thiol proteases (48) , also inhibits ECM degradation to 37% of control. The combined use of leupeptin and NPGB did not alter significantly the inhibition pattern exhibited by either compound alone (Fig. 6B ). This result is in contrast to the combined use of the more general protease inhibitors (Fig.  6A ) and suggests that a specific arginine-preferring serine protease is partially responsible for the degradation of ECM by RSV-transformed cells.
Effect of Serum and Serum Components on ECM Degradation
All of the previously described ECM degradation studies were performed in serum-free medium. Since FCS that contains plasminogen (35) is a standard supplement of transformed cell cultures, we examined the effect of FCS supplementation on matrix degradation (Fig. 7) . Adding 5% FCS to cultures of TPA-treated RSVCEFs incubated on radiolabeled ECM increases the degradation of ECM over that of parallel cultures incubated in serum-free medium. This increase in degradation (5 to 15% after 6 h, 40 to 55% after 24 h) is not as substantial as the increase observed when purified plasminogen is added to serum-free cultures (Fig. 4) . Since this might be due to natural protease inhibitors present in serum, FCS was acid treated and reneutralized to inactivate most of the protease inhibitory capacity of FCS (40) . Acid-treated FCS enhanced the degradation of ECM by RSVCEFs (25% after 6 h and 70% after 24 h) to levels similar to those observed when purified plasminogen was added to serum-free cultures (Fig. 4) . That the increase in ECM degradation in the presence of FCS or acid-treated FCS was dependent on serum plasminogen is illustrated by the reduction in ECM degradation that occurs when plasminogen-depleted FCS or plasminogen-de-
pleted, acid-treated FCS is used as a supplement (Fig. 7) . The plasminogen depletion of FCS by lysine Sepharose affinity chromatography used in these experiments selectively removes >98% of the plasminogen in serum (35).
ECM Degradation by Transformed Cells in Direct Contact with or Separated from ECM: Effect of Plasminogen and the Protease Inhibitor ~2M
Degradation of ECM proteins by transformed cells could be mediated by cell surface proteolytic enzymes or by secreted proteolytic enzymes or both. To examine these possibilities, Preparations of radiolabeled ECM on plastic disks were floated (ECM facing downward) in serum-free medium 1 2 mm above a monolayer of 4 x 106 RSVCEF cells (separated conditionsj or placed in culture dishes (ECM facing upward) with 4 x 106 RSVCEF cells seeded on top of the disks (contact (onditions). TPA (100 ng/ml) was added to all cultures. Some of the cultures received 2/~g purified chicken plasminogen (lines c, d, g, and h) and some cultures received 180/~g purified human a2M (lines a, d, f, and h). Control dishes contained radiolabeled ECM in medium alone (without cells) in the absence or presence of plasminogen (lines i and/). At the indicated times, the culture medium was analyzed for the release of radioactivity as described in Materials and Methods. All the cultures were analyzed in triplicate and the numbers represent the mean percent radioactivity released with the standard deviation <10% of the individual mean values.
transformed cells were incubated either in direct physical contact with radiolabeled ECM or separated from the ECM. We separated cells from ECM by preparing ECM on plastic tissue culture disks and floating the disks in the medium above a monolayer of RSVCEFs separated from the cells by a distance of 1-2 ram. An equivalent number of RSVCEF were plated onto the ECM disks in direct contact with the ECM in parallel experiments. The results of these experiments are shown in Table I . Cells in direct contact with ECM degraded the matrix at a relatively slow but progressive rate (Table I , line a) similar to that observed in Fig. 4 . When an equivalent number of RSVCEF cells were separated from the ECM a substantial reduction in ECM degradation was observed (Table I , compare lines a and e). This suggests that cell-mediated ECM degradation is brought about mainly by cell surface proteases or enzymes closely juxtaposed with the cell surface. When plasminogen was added to the cultures (Table I , line c) a rapid degradation of ECM occurred under contact conditions, similar to that observed in Fig. 4 . A similar rapid ECM degradation occurred under separated conditions in the presence of plasminogen (Table I, compare lines c and g ). This result is consistent with the conversion of plasminogen to plasmin by cellular PA, and plasmin, being soluble and diffusable, can rapidly degrade the separated ECM.
The addition of a2M to the cultures further illustrates a distinct difference between cell contact-mediated ECM degradation and ECM degradation by diffusable enzymes. Under conditions of cell/ECM separation, c~2M inhibits cellular enzyme-mediated, plasminogen-independent degradation 1796 THE JOURNAL OF CElL BIOLOGY • VOLUME 101, 1985 (Table I , lines e and f) and substantially inhibits the plasminogen-dependent degradation (Table I, lines g and h) . Under conditions ofcell/ECM contact, plasminogen-dependent degradation is partially inhibited by a2M (Table I , lines c and d), whereas the cell-mediated, plasminogen-independent degradation is not inhibited early (23 h) and inhibited only 25% later (Table I , lines a and b). The partial inhibition by c~2M observed later could be accounted for by c~2M inhibition of diffusable cellular enzymes since, in Table I , ~25-30% of the degradation observed in line a is due to diffusable cellular enzymes (line e), which are substantially inhibited by a2M (line JO. Thus c~2M, a broad spectrum protease inhibitor, inhibits ECM degradation by the soluble, diffusable enzymes generated by the transformed cells but has little effect on enzymes closely juxtaposed with the ECM.
DISCUSSION
Normal CEFs produce an ECM, highly enriched in fibronectin, that restricts and alters the behavior of RSVCEFs when the latter are cultured on the ECM. The RSVCEF cells become enmeshed within the matrix network and lose their characteristic rounded refractile and disoriented morphology (Fig. 2f) . These results are consistent with the observations made by other laboratories that exogenous fibronectin restores a more "normal" morphology to transformed fibroblasts (24) (25) (26) . The present study demonstrates, however, that this restorative ability of ECM components is only shortlived. The transformed cells, unlike the normal CEFs, can progressively degrade the proteins of ECM and thereby overcome the restrictive properties of the underlying matrix. This is especially pronounced when the transformed cells are treated with the tumor promoter TPA, which induces a highly transformed phenotype (28, 29) . Concomitant with matrix degradation, the TPA-treated transformed cells regain their abnormal morphology and migrate or rearrange in culture to form multicellular clusters (Fig. 2 h) .
The nature of the degradative ability of transformed fibreblasts is complex, but the present study illustrates some aspects of their catalytic activity toward ECM. When a source of plasminogen is present, the degradation of the ECM is rapid and extensive (Fig. 4) due to the conversion of inactive plasminogen to the active protease plasmin by the elevated levels of PA produced by the transformed cells (29, 30) . If serum is present, RSVCEF-mediated ECM degradation occurs, but its rate and extent are controlled by the presence of acidqabile protease inhibitors in the serum (Fig. 7) . The rapid clearing of matrix in the presence of serum appears to be due mainly to plasmin since selective removal of plasminogen from serum reduces ECM degradation to the level observed in serum-free medium. This plasminogen dependence in the presence of serum was not observed by Kramer et al. (20) in studies on endothelial ECM degradation by B i6 melanoma cells. However, studies from other laboratories that demonstrated degradation of endothelial ECM by highly tumorigenic fibrosarcoma cells (18) and lung tissue matrix degradation by metastatic tumor cells (21) indicate that serum plasminogen is involved in transformed cell-mediated matrix degradation.
The present studies also demonstrate that a plasminogenindependent ECM degradation can occur. This degradation is not as rapid as plasmin-dependent degradation, but, it is progressive, and eventually all or most of the ECM present in a culture dish is solubilized (Fig. 4) . Although such plasminogen-independent degradation has been observed by several laboratories that employed various tumor cells (20) (21) (22) , the enzymatic nature of the process remained unresolved. In the CEF/RSVCEF culture systems described herein, certain aspects of the process have been resolved. First, the process is mediated by cellular enzymes distinct in specificity from plasmin since it is completely insensitive to trasylol (Fig. 4) and the polypeptide patterns of solubilized components are distinct from plasmin-mediated degradation patterns (Fig. 5) . Second, the cell-mediated degradation of ECM is partially sensitive to a few selective inhibitors of arginine-preferring serine proteases (Fig, 6 B) . However, partial sensitivity to these inhibitors suggests that a number of other types of cellular enzymes also are active in ECM degradation. The sensitivity of ECM degradation to E64c and 1,10 phenanthroline, respectively, (Fig. 6A) suggests that cysteine and metallo-proteases are directly involved in matrix degradation. The identity of these proteolytic enzymes is unresolved, but Chen et al. (49) observed that clearing of fibronection spots at cell substratum contact sites was inhibited by 1,10 phenanthroline, which supports the involvement of a transformationassociated metallo-protease.
These studies suggested the identity of the arginine-specific protease(s). Previous studies (29) from this laboratory have indicated that the distinct morphological alterations that occur in TPA-treated RSVCEF cultures are mediated in part by the direct catalytic activity of PA, an arginine-preferring serine protease. The PA activity in this culture system is elevated upon TPA treatment (28) , is found associated with a plasma membrane-like fraction (27) , and is sensitive to diisopropylfluorophosphate, NPGB, and leupeptin but insensitive to trasylol (29) . These results are consistent with a direct catalytic role for PA independent ofplasminogen in ECM degradation. Conclusive proof, however, that PA can directly hydrolyze matrix proteins must await studies with specific antibodies that inhibit the catalytic activity of PA. Such experiments are under investigation. 2 A major part of the cell-mediated, plasminogen-independent ECM degradation requires close contact between cells and ECM (Table I) . These results suggest that cell-surface protease(s) or secreted protease(s) in close apposition to the cell surface are involved in ECM degradation. Recent studies from other laboratories have indicated that ECM degradation by mouse trophoblasts (50) and virus-transformed fibroblasts (49) is highly localized and appears to occur at cell/ECM contact sites. Studies by Mahdavi and Hynes (51) have also indicated that close contact between transformed, cells and normal cells was required to degrade the fibronectin present on the normal cells. When the cell types were separated by short distances little or no loss of fibronectin occurred.
The ECM degradation that occurs when RSVCEF cultures are in direct contact with the matrix is insensitive to the serum protease inhibitor a2M. The a2M is a broad spectrum protease inhibitor that inhibits all known proteolytic enzymes (52) including RSVCEF plasminogen activator (unpublished observations). The inability of this molecule to inhibit cell contact-mediated ECM degradation suggests that a2M, a large molecular weight protein, cannot gain access to the protease(s) operating at close ECM/cell contact points. ECM 2 Matrix degradation by RSVCEF is inhibited 35-50% by a highly specific monoclonal antibody directed against avian PA (manuscript in preparation).
degradation that occurs when cells and ECM are separated, mediated either by plasmin or proteases secreted by cells, is, in contrast, highly sensitive to a2M (Table I) . Thus, the cellmediated degradation of ECM by malignant cells at close contact points is more insidious since it can occur in the virtual absence of serum and plasminogen and is refractory to control by natural protease inhibitors such as trasylol and a2M.
The study of ECM degradation by cultured transformed cells can serve as a model system for tumor cell invasion and can also indicate specific enzymes and classes of enzymes involved in matrix degradation, but the model has a number of limitations. The ECM prepared from cultured fibroblasts may not be totally representative of the connective tissue matrix that is laid down in vivo. In the present study the ECM produced by embryonic chick fibroblasts is composed mainly of fibronectin and contains relatively less collagen and other connective tissue components. However, studies from Liotta's laboratory have clearly indicated that collagen breakdown is an important aspect of tumor cell invasion (17, 53, 54) , and reports by Kramer et al. and Nakajima et al. have shown that degradation of matrix proteoglycans is characteristic of the invasive capacity of a tumor cell (20, 55) . Thus, a fibronectin-enriched, embryonic fibroblast matrix is only a limited model system for studying malignant cell invasion. Nevertheless, the present study, employing a homologous cell system of transformed chick cells cultured on normal chick ECM, has indicated that elevated levels of PA in transformed cells can bring about a rapid degradation of fibronectin and other matrix proteins through the generation of plasmin. In the absence of plasminogen, the transformed cells can use their locally secreted and surface enzymes, including possibly the direct catalytic action of PA to bring about a progressive degradation of matrix in the immediate vicinity of the cells even in the presence of natural protease inhibitors. Once the matrix under and around the cells has been solubilized, its adhesive and restrictive aspect is thus eliminated, releasing the maligant cells to continue along their migratory, degradative, and invasive pathway,
